Healthcare provider profile · identity verified

Dylan Eldon Stentiford, M.D.

Internal Medicine · ATLANTA, GA · NPI 1134389588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	601	192
Atorvastatin Calcium	Atorvastatin Calcium	551	179
Gabapentin	Gabapentin	317	110
Fluticasone Propionate	Fluticasone Propionate	293	133
Losartan Potassium	Losartan Potassium	228	78
Furosemide	Furosemide	220	68
Tamsulosin Hcl	Tamsulosin Hcl	210	66
Carvedilol	Carvedilol	204	67
Albuterol Sulfate Hfa	Albuterol Sulfate	197	69
Lisinopril	Lisinopril	194	67
Hydrochlorothiazide	Hydrochlorothiazide	193	77
Levothyroxine Sodium	Levothyroxine Sodium	192	64
Rosuvastatin Calcium	Rosuvastatin Calcium	180	67
Azelastine Hcl	Azelastine Hcl	166	75
Famotidine	Famotidine	160	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	160	26
Metformin Hcl	Metformin Hcl	155	52
Pantoprazole Sodium	Pantoprazole Sodium	154	52
Omeprazole	Omeprazole	146	52
Potassium Chloride	Potassium Chloride	145	50
Metoprolol Succinate	Metoprolol Succinate	134	55
Ozempic	Semaglutide	134	36
Pravastatin Sodium	Pravastatin Sodium	134	41
Eliquis	Apixaban	124	35
Diclofenac Sodium	Diclofenac Sodium	119	52
Spironolactone	Spironolactone	98	27
Trazodone Hcl	Trazodone Hcl	96	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	31
Nifedipine Er	Nifedipine	84	32
Prednisone	Prednisone	84	54
Montelukast Sodium	Montelukast Sodium	80	22
Lidocaine	Lidocaine	79	22
Metformin Hcl Er	Metformin Hcl	79	28
Duloxetine Hcl	Duloxetine Hcl	75	27
Celecoxib	Celecoxib	73	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	23
Alendronate Sodium	Alendronate Sodium	66	18
Ezetimibe	Ezetimibe	65	23
Metoprolol Tartrate	Metoprolol Tartrate	65	21
Allopurinol	Allopurinol	62	22
Escitalopram Oxalate	Escitalopram Oxalate	62	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	14
Valacyclovir	Valacyclovir Hcl	59	27
Clonazepam	Clonazepam	55	suppressed
Ondansetron Hcl	Ondansetron Hcl	55	30
Pregabalin	Pregabalin	55	16
Hydroxyzine Hcl	Hydroxyzine Hcl	54	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	14
Mirtazapine	Mirtazapine	52	22
Mounjaro	Tirzepatide	51	13
Hydralazine Hcl	Hydralazine Hcl	50	15
Meloxicam	Meloxicam	50	16
Simvastatin	Simvastatin	50	18
Torsemide	Torsemide	48	29
Clopidogrel	Clopidogrel Bisulfate	47	17
Tramadol Hcl	Tramadol Hcl	47	29
Jardiance	Empagliflozin	45	14
Alprazolam	Alprazolam	44	11
Quetiapine Fumarate	Quetiapine Fumarate	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	14
Citalopram Hbr	Citalopram Hydrobromide	40	13
Nystatin	Nystatin	40	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	12
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Finasteride	Finasteride	38	15
Ibuprofen	Ibuprofen	37	16
Sertraline Hcl	Sertraline Hcl	37	14
Triamcinolone Acetonide	Triamcinolone Acetonide	37	24
Loperamide	Loperamide Hcl	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	12
Chlorthalidone	Chlorthalidone	35	suppressed
Trulicity	Dulaglutide	34	14
Azithromycin	Azithromycin	33	28
Xarelto	Rivaroxaban	33	suppressed
Januvia	Sitagliptin Phosphate	32	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	11
Synthroid	Levothyroxine Sodium	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	13
Farxiga	Dapagliflozin Propanediol	31	13
Valsartan	Valsartan	31	12
Colchicine	Colchicine	30	suppressed
Klor-Con M10	Potassium Chloride	30	11
Levetiracetam	Levetiracetam	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	14
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Atenolol	Atenolol	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	27	26
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Fluconazole	Fluconazole	25	18
Rybelsus	Semaglutide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Naproxen	Naproxen	20	11
Premarin	Estrogens, Conjugated	20	suppressed
Creon	Lipase/Protease/Amylase	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Linzess	Linaclotide	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Baclofen	Baclofen	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Lorazepam	Lorazepam	18	11
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Cephalexin	Cephalexin	17	16
Clotrimazole	Clotrimazole	17	11
Ketoconazole	Ketoconazole	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Mesalamine	Mesalamine	16	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Epinephrine	Epinephrine	15	suppressed
Estradiol	Estradiol	15	suppressed
Glipizide	Glipizide	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Mupirocin	Mupirocin	15	11
Myrbetriq	Mirabegron	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Promethegan	Promethazine Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Clonidine	Clonidine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Klonopin	Clonazepam	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Risperidone	Risperidone	11	suppressed
Sandostatin Lar Depot	Octreotide Acetate,mi-Spheres	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error